Brind.

RenaissanceRe (RNR) is being reviewed by Barclays, which upgraded the stock to Equal Weight and Fitch rated the company's business profile as Moderate, citing benefits from Trump-era tariffs.

1 report, 1 independent Updated Jul 16

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

RenaissanceRe Donald Trump Barclays

Keep exploring

The entities involved

RenaissanceRe
Bermudian company

Nothing else this week.
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- CIA documents were cited in diplomatic discussions involving Donald Trump.20:34
- Donald Trump is expected to sign park legislation.20:28
Barclays
British bank
- Barclays released a research report addressing current demand trends in the AI infrastructure market.19:26
- Marsh and Barclays are lobbying the Federal Reserve to ease bank capital rules and seek capital relief.18:06

Related events

Banks like Mizuho, Deutsche Bank, and Goldman Sachs maintained or raised ratings for Harmony Biosciences, citing benefits from tariffs and onshoring trends for AI stocks.Jun 8

Coverage

Newest first; wire copies grouped

Jul 16Insider MonkeyBarclays Upgrades RenaissanceRe Holdings (RNR) Stock to Equal Weight, Lifts PT RenaissanceRe Holdings Ltd. (NYSE:RNR) is one of the Best Large Cap Value Stocks to Invest In. Barclays upgraded the com